
Medicovestor
Developer of antibody-drug conjugate cancer therapy designed to merge antibodies' efficacy with the potency of small-molecule anticancer drugs. The company's precision medicines are meticulously craft...
Valuation
$53M
Latest known
Share Price
N/A
Total Raised
$6.3M
Last Round
N/A